TickerFiles

AVENUE THERAPEUTICS, INC. 10-Q filing

Filed 2026-05-08 · Report date 2026-03-31 · 2026

View Original SEC Filing

Filing metadata

Accession number
0001437749-26-015759
Form type
10-Q
CIK
0001644963
Primary document
https://www.sec.gov/Archives/edgar/data/1644963/000143774926015759/atxi20260331_10q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for AVENUE THERAPEUTICS, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-714,000--
Net Income$-695,000--
Eps Basic-0.21--
Cash And Equivalents$2.4M--
Total Assets$2.5M--
Total Liabilities$1.3M--
Shareholders Equity$1.2M--
Operating Cash Flow$-438,000--